It is clear that the value of e’ decreased significantly from baseline to the end of the 3 rd cycle of chemotherapy in patients with ASIC (d = -1.33 ± 0.34), while that of e’ had an increasing trend in patient without AISC (d = 0.14 ± 1.65).
← all excerpts
Study on influencing factors of anthracycline-induced subclinical cardiotoxicity in DLBCL patients administered (R)-CHOP.
1
—
—